Yokohama, Japan

Rei Kaneto

This inventor holds 1 USPTO granted patent. Top assignee: Mercian Corporation. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rei Kaneto. Retrieved from https://idiyas.com/inventor/rei-kaneto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Rei Kaneto

Introduction

Rei Kaneto is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of antibiotics, particularly with his innovative work on Mer-AF1032A and Mer-AF1032B. His research has the potential to impact the pharmaceutical industry positively.

Latest Patents

Rei Kaneto holds a patent for antibiotics Mer-AF1032A and Mer-AF1032B. The antibiotic Mer-AF1032A is represented by a specific formula, and its isomer, antibiotic Mer-AF1032B, is also disclosed in the patent. The patent outlines a method for preparing these antibiotics, which involves cultivating a strain belonging to the genus Penicillium. Additionally, it includes a pharmaceutical composition that comprises one of these antibiotics, which is useful as an antifungal agent.

Career Highlights

Rei Kaneto is associated with Mercian Corporation, where he has been able to apply his expertise in antibiotic development. His work has garnered attention for its innovative approach to combating fungal infections.

Collaborations

Rei Kaneto has collaborated with notable colleagues, including Hitosi Agematu and Yoshio Watanabe. These collaborations have contributed to the advancement of his research and the development of new pharmaceutical solutions.

Conclusion

Rei Kaneto's contributions to antibiotic research exemplify the importance of innovation in the pharmaceutical industry. His work on Mer-AF1032A and Mer-AF1032B showcases the potential for new treatments in combating infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…